U.S. Online Retail and Ecommerce Stock News

Why MSCI’s latest earnings, buybacks and dividend move matter MSCI (MSCI) is back in the spotlight after its fourth quarter and full year 2025 results, updated share repurchase activity, and a higher cash dividend, all of which directly affect shareholder returns. For the fourth quarter, MSCI reported sales of US$822.53 million, compared with US$743.51 million a year earlier. Net income was US$284.67 million versus US$305.52 million, with diluted earnings per share from continuing operations...

Pfizer (PFE) is back in the obesity spotlight after reporting Phase 2b VESPER-3 data for its monthly GLP-1 injection, PF-3944, showing up to 12.3% placebo adjusted weight loss at week 28. See our latest analysis for Pfizer. The PF-3944 data lands after a busy spell for Pfizer, including better than expected Q4 2025 adjusted earnings, reaffirmed 2026 revenue guidance, a fresh Priority Review for hemophilia drug HYMPAVZI, and ongoing cost and pricing pressures such as TrumpRx agreements. The...

KKR (NYSE:KKR) has agreed to acquire Arctos Partners, moving directly into investments in professional sports franchises. The firm plans to create a new unit called KKR Solutions, with Arctos forming a key part of this expanded platform. Separately, KKR has agreed to acquire a majority stake in ST Telemedia Global Data Centres, one of Asia's largest data center operators. The ST Telemedia Global Data Centres deal is described as KKR's largest infrastructure investment in Asia Pacific. For...

Streamex Corp. recently appointed Anthony Marciano, Clinical Professor of Finance at NYU Stern and former senior Wall Street banker, as an independent director to its Board, adding deep expertise in corporate finance, mergers and acquisitions, and capital markets. Marciano’s combination of academic influence and high-level investment banking experience may reinforce Streamex’s governance credentials as it expands its tokenization and capital markets initiatives. Next, we will examine how...

Why GSBR-1290’s phase 2 progress matters for Structure Therapeutics (GPCR) Structure Therapeutics (GPCR) is back in focus as its oral obesity candidate GSBR-1290 advances through phase 2 trials. This is a key clinical stage that can materially influence sentiment around the company’s pipeline and valuation. See our latest analysis for Structure Therapeutics. At a share price of US$74.92, Structure Therapeutics has had a mixed short term pattern, with a 1 day share price return of 2.34% but a...

If you are wondering whether STERIS is priced fairly at around US$252 per share, you are not alone; many investors are asking whether the current tag matches the underlying business. The stock has had a mixed run recently, with a 4% decline over the last week, a 1.8% decline over the last month, but returns of 0.8% year to date, 14.1% over 1 year, 34.6% over 3 years and 44.3% over 5 years. Recent news coverage has focused on STERIS as a key player in healthcare equipment and services, which...

FuboTV (NYSE:FUBO) reports Q4 revenue that comes in above its own expectations. The company highlights progress on a planned Hulu Live integration to broaden content access for subscribers. Management addresses an ongoing dispute with NBCUniversal while emphasizing continuity of its service. FuboTV adopts new monetization approaches using Disney's ad platform to refine its advertising business. FuboTV operates in the crowded live TV streaming market, where viewers are trading traditional...

Hydrorich Cream launch and why Honest Company (HNST) is back on investors’ radars Honest Company (HNST) just expanded its skincare lineup with Hydrorich Cream, a new moisturizer aimed at dry and extra dry skin, and investors are asking what this means for the stock. See our latest analysis for Honest Company. Hydrorich Cream arrives at a time when Honest Company’s short term trading has been choppy, with a 7 day share price return of 7.29% decline and a 30 day share price return of 11.24%...

Board appointment and Israel partnership draw fresh attention to GlobalFoundries stock GlobalFoundries (GFS) is back in focus after a new partnership with Telsys in Israel and the appointment of Mubadala executive Samer Halawa to its Board and Strategy & Investment Committee. See our latest analysis for GlobalFoundries. The Telsys agreement and new board appointment arrive after a 23.95% 90 day share price return and a 16.38% year to date share price return, while the 3 year total shareholder...

Exponent, Inc. recently reported fourth-quarter 2025 results showing year-on-year growth in sales and revenue, modestly higher earnings per share, and full-year 2025 revenue of US$582.01 million alongside a slightly lower annual net income of US$106.01 million. The company paired this earnings beat with guidance for high-single-digit revenue growth in 2026, an increased quarterly dividend to US$0.31 per share, and emphasis on demand tied to artificial intelligence, user research, and risk...

Wondering if Forestar Group at around US$29.27 is offering genuine value or if the easy gains are already behind it? This article walks through the key numbers so you can judge the price with more confidence. The stock has delivered returns of 12.5% over 7 days, 6.8% over 30 days, 20.4% year to date, 27.8% over 1 year and a very large 3 year gain. This naturally raises questions about how much of the good news might already be reflected in the share price. Recent price moves are set against...

If you are wondering whether Monster Beverage's current share price really reflects what you are getting for your money, you are not alone. This article is written with that question front and center. The stock last closed at US$82.54, with reported returns of 2.2% over 7 days, 6.7% over 30 days, 8.4% year to date, 77.2% over 1 year and 80.0% over 5 years. This naturally raises questions about how the present price lines up with underlying value. Recent news coverage around Monster Beverage...

Dole plc announced it will begin filing using U.S. domestic issuer forms while keeping its foreign private issuer status. The company plans to transition its filings going forward to align more closely with U.S. reporting practices. This change is intended to increase comparability with U.S. public companies and may affect index eligibility. Dole (NYSE:DOLE) is making a reporting shift that could matter if you follow U.S. equities closely. By choosing domestic issuer forms while retaining...

NIO (NYSE:NIO) expects to report its first quarterly adjusted operating profit in Q4 2025, marking a major shift after years of losses. The company reports record monthly and quarterly deliveries, including a 96% year over year delivery increase in January 2026. Management links the profit milestone to stronger sales, better vehicle margins, and cost reduction efforts across the business. NIO, trading at around $5.04 per share, sits at an interesting point in its story, with the stock up...

Macy’s has accelerated its restructuring by closing a major fulfillment center in Owasso, Oklahoma, and moving ahead with most of 14 planned store closures, affecting hundreds of jobs as it streamlines its supply chain and store base. These steps, part of a broader transformation plan, raise fresh questions about how Macy’s will balance reinvestment needs with its ongoing dividend payments to shareholders. We’ll now look at how accelerated store closures and supply-chain changes may reshape...

If you are wondering whether Sila Realty Trust is priced fairly or if there is still value on the table, this article will walk through what the current share price might be telling you. The stock last closed at US$25.06, with recent returns of 2.9% over 7 days, 7.5% over 30 days, 6.6% year to date, 5.8% over 1 year and 9.6% over 5 years, which provides some context for how the market has been reacting. Recent news coverage around Sila Realty Trust has focused on its position within the US...

American Tower (NYSE:AMT) appointed Paul Blanchett as Senior Vice President and Chief Accounting Officer, marking a leadership change at the corporate level. CoreSite, an American Tower subsidiary, received industry recognition as Chief Revenue Officer Maile Kaiser was named to the 2026 CRN Channel Chiefs list. The news highlights leadership shifts and partner focused initiatives tied to data center growth and AI enablement within the broader American Tower platform. American Tower, through...

RXO (NYSE:RXO) has arranged a new US$450 million asset based lending facility, replacing prior credit agreements. The company has recorded a goodwill impairment in response to ongoing freight market pressures. RXO is advancing AI driven tools and building a larger late stage sales pipeline to support performance. RXO runs an asset light freight brokerage and logistics business, so prolonged weakness in freight markets directly affects pricing, shipment volumes, and the value of certain...

In early February 2026, PharosAI announced it will use 10x Genomics’ Xenium spatial platform to convert thousands of archived NHS cancer samples into high-resolution, multimodal datasets for AI-driven research, backed by PS18.9 million in UK government funding plus additional charity and industry support. This collaboration links 10x Genomics’ spatial biology technology with a major UK cancer initiative that plans to democratize AI-ready datasets for global researchers, clinicians and...

If you are wondering whether PagSeguro Digital is still attractively priced or if the easy gains are already behind it, looking closely at its valuation metrics can help you frame that question clearly. The share price recently closed at US$10.99, with returns of 6.8% over 30 days, 13.7% year to date, 56.0% over 1 year, 27.5% over 3 years and an 81.3% decline over 5 years. This gives a mixed picture of how the market has treated the stock over different timeframes. Recent news flow around...

NovoCure (NVCR) has drawn attention after a prolonged share price slump, with negative returns over the past year and the past 3 months prompting investors to reassess how its current valuation lines up with its oncology device business. See our latest analysis for NovoCure. The recent 7 day share price return of 18.23% decline and 30 day share price return of 29.34% decline add to a year long total shareholder return of 54.43% decline. This points to fading momentum as investors reassess...

In January 2026, Honeywell International reported fourth-quarter 2025 results showing higher revenue of US$9,758 million but sharply lower net income of US$295 million, reflecting sizeable goodwill and asset impairment charges, while also issuing 2026 guidance for sales of US$38.80–US$39.80 billion and diluted EPS of US$9.59–US$9.89 from continuing operations. Investor attention also centered on Honeywell’s planned aerospace spinoff and a fresh analyst upgrade, as the company framed these...

In late January 2026, SoundHound AI announced an expanded relationship with Five Guys, extending its voice-powered ordering agents across hundreds of locations after handling well over a million customer interactions. Together with recent enterprise wins in insurance, financial services, and a Bridgepointe Technologies partnership, this points to a broadening footprint for SoundHound’s conversational AI across both consumer-facing and back-office use cases. With recent share price gains and...

Federal Realty Investment Trust sold Misora Apartments at Santana Row and Courthouse Center as part of its capital recycling program. The transactions generated significant proceeds that the company plans to redirect into higher return opportunities. The moves reflect an active approach to refining the NYSE:FRT portfolio while seeking to preserve financial flexibility. For you as an investor, the key point is that NYSE:FRT is reshaping its mix of assets rather than simply adding more...